Clinical Trial Update: Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of somatostatin for acute severe upper gastrointestinal bleeding due to peptic ulcer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: UCB Pharma | Conditions: Peptic Ulcer | Phase 2 | Status: COMPLETED